152 related articles for article (PubMed ID: 2747625)
1. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
Spivak CE; Waters JA; Aronstam RS
Mol Pharmacol; 1989 Jul; 36(1):177-84. PubMed ID: 2747625
[TBL] [Abstract][Full Text] [Related]
2. Potencies and channel properties induced by semirigid agonists at frog nicotinic acetylcholine receptors.
Spivak CE; Waters J; Witkop B; Albuquerque EX
Mol Pharmacol; 1983 Mar; 23(2):337-43. PubMed ID: 6300643
[TBL] [Abstract][Full Text] [Related]
3. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
Kem WR; Mahnir VM; Papke RL; Lingle CJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
[TBL] [Abstract][Full Text] [Related]
4. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
Weiland GA; Durkin JA; Henley JM; Simasko SM
Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors.
Anis N; Sherby S; Goodnow R; Niwa M; Konno K; Kallimopoulos T; Bukownik R; Nakanishi K; Usherwood P; Eldefrawi A
J Pharmacol Exp Ther; 1990 Sep; 254(3):764-73. PubMed ID: 2168484
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
Swanson KL; Aronstam RS; Wonnacott S; Rapoport H; Albuquerque EX
J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
Min CK; Owens J; Weiland GA
Mol Pharmacol; 1994 Feb; 45(2):221-7. PubMed ID: 7509439
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
9. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
[TBL] [Abstract][Full Text] [Related]
10. Carbamyl analogues of potent nicotinic agonists: pharmacology and computer-assisted molecular modeling study.
Spivak CE; Yadav JS; Shang WC; Hermsmeier M; Gund TM
J Med Chem; 1989 Feb; 32(2):305-9. PubMed ID: 2913294
[TBL] [Abstract][Full Text] [Related]
11. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
Chiara DC; Xie Y; Cohen JB
Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
[TBL] [Abstract][Full Text] [Related]
12. Structural and electronic requirements for potent agonists at a nicotinic receptor.
Spivak CE; Gund TM; Liang RF; Waters JA
Eur J Pharmacol; 1986 Jan; 120(1):127-31. PubMed ID: 3485051
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
Hoover RK; Toews ML
J Pharmacol Exp Ther; 1989 Oct; 251(1):63-70. PubMed ID: 2795471
[TBL] [Abstract][Full Text] [Related]
15. Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor.
Carter CR; Cao L; Kawai H; Smith PA; Dryden WF; Raftery MA; Dunn SM
Biochem Pharmacol; 2007 Feb; 73(3):417-26. PubMed ID: 17118342
[TBL] [Abstract][Full Text] [Related]
16. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor.
Costa AC; Swanson KL; Aracava Y; Aronstam RS; Albuquerque EX
J Pharmacol Exp Ther; 1990 Feb; 252(2):507-16. PubMed ID: 1690291
[TBL] [Abstract][Full Text] [Related]
17. Interaction of a semirigid agonist with Torpedo acetylcholine receptor.
Kawai H; Cao L; Dunn SM; Dryden WF; Raftery MA
Biochemistry; 2000 Apr; 39(14):3867-76. PubMed ID: 10747774
[TBL] [Abstract][Full Text] [Related]
18. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors.
Ward TR; Ferris DJ; Tilson HA; Mundy WR
Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012
[TBL] [Abstract][Full Text] [Related]
19. 3-Chlorodibenzazepine binding to cholinergic receptors and ion channels.
Aronstam RS; Narayanan L
Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):551-4. PubMed ID: 6275473
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor.
Sherby SM; Eldefrawi AT; Albuquerque EX; Eldefrawi ME
Mol Pharmacol; 1985 Mar; 27(3):343-8. PubMed ID: 3974572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
